Literature DB >> 21045182

Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.

Masatoshi Hori1, Tonsok Kim, Hiromitsu Onishi, Takashi Ueguchi, Mitsuaki Tatsumi, Atsushi Nakamoto, Takahiro Tsuboyama, Kaname Tomoda, Noriyuki Tomiyama.   

Abstract

PURPOSE: To compare a three-dimensional (3D) T2-weighted turbo spin-echo (TSE) magnetic resonance (MR) sequence (VISTA; Philips Medical Systems, Best, the Netherlands) with a two-dimensional (2D) T2-weighted TSE sequence in terms of image quality, signal intensity (SI) difference ratios, conspicuity, and staging of uterine tumors.
MATERIALS AND METHODS: This retrospective study was approved by the institutional review board, and informed consent was waived. Sixty-one women (mean age, 53.0 years ± 13.7 [standard deviation]; range, 30-87 years) with cervical carcinoma (n = 28), endometrial carcinoma (n = 21), or leiomyoma (n = 30) of the uterus were included. Patients underwent T2-weighted MR imaging at 3 T with both 1-mm-thick 3D and 5-mm-thick 2D T2-weighted TSE sequences. Three-dimensional T2-weighted TSE images were reconstructed at 5-mm thickness with the aid of a workstation. Quantitative analyses of signal-to-noise ratio (SNR) and SI difference ratios between tumors and other tissues and qualitative analyses of image quality and tissue conspicuity were performed. Two radiologists independently assessed local-regional staging for carcinomas. Quantitative values, qualitative scores, and tumor staging were analyzed by using the paired t test, Wilcoxon signed rank test, and McNemar test, respectively.
RESULTS: Mean myometrial SNR was higher on 3D than 2D images (14.3 vs 9.8; P < .0001). Mean SI difference ratios between cervical (0.45 vs 0.34; P < .0001) or endometrial (0.46 vs 0.40; P = .044) carcinomas and gluteal muscle were higher on 3D images, but those between leiomyoma and myometrium (0.33 vs 0.43; P < .0001) were lower than those on 2D images. Image quality (P = .0004) and carcinoma conspicuity (P < .0005) were superior with the 3D T2-weighted TSE sequence. Although multiplanar reconstruction of 3D T2-weighted TSE images was useful for staging in one case, there were no significant differences between 3D and 2D T2-weighted TSE imaging in accuracy of staging for the two readers for cervical or endometrial carcinoma.
CONCLUSION: The 3D T2-weighted TSE sequence showed certain advantages over the 2D T2-weighted TSE sequence, and it has the potential to improve the performance of MR imaging for the evaluation of uterine carcinoma. © RSNA, 2010.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21045182     DOI: 10.1148/radiol.10100866

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

1.  Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection.

Authors:  Andrew B Rosenkrantz; Hersh Chandarana; Nicole Hindman; Fang-Ming Deng; James S Babb; Samir S Taneja; Christian Geppert
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

2.  Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.

Authors:  Lucia Manganaro; Yulia Lakhman; Nishat Bharwani; Benedetta Gui; Silvia Gigli; Valeria Vinci; Stefania Rizzo; Aki Kido; Teresa Margarida Cunha; Evis Sala; Andrea Rockall; Rosemarie Forstner; Stephanie Nougaret
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

3.  MRI for prostate cancer: can computed high b-value DWI replace native acquisitions?

Authors:  Salma Jendoubi; Mathilde Wagner; Sarah Montagne; Malek Ezziane; Julien Mespoulet; Eva Comperat; Candice Estellat; Amandine Baptiste; Raphaele Renard-Penna
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

Review 4.  Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: An updated systematic review and meta-analysis of the literature between 2012 and 2016.

Authors:  Sungmin Woo; Chong Hyun Suh; Sang Youn Kim; Jeong Yeon Cho; Seung Hyup Kim
Journal:  Eur Radiol       Date:  2017-07-19       Impact factor: 5.315

Review 5.  Clinical utility of optimized three-dimensional T1-, T2-, and T2*-weighted sequences in spinal magnetic resonance imaging.

Authors:  Nobuko Tanitame; Keizo Tanitame; Kazuo Awai
Journal:  Jpn J Radiol       Date:  2017-02-23       Impact factor: 2.374

6.  Assessing 3D T2 FSE sequence for identification of the normal appendix: working toward a single-sequence MR appendicitis protocol.

Authors:  Nattinee Leelakanok; Andrew S Phelps; Matthew A Zapala; Kambrie Kato; Michael Ohliger; Yi Li; Jesse Courtier
Journal:  Emerg Radiol       Date:  2017-07-19

Review 7.  Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis.

Authors:  Maarten G Thomeer; Cees Gerestein; Sandra Spronk; Helena C van Doorn; Els van der Ham; Myriam G Hunink
Journal:  Eur Radiol       Date:  2013-03-01       Impact factor: 5.315

8.  Endometrial cancer: preoperative staging using three-dimensional T2-weighted turbo spin-echo and diffusion-weighted MR imaging at 3.0 T: a prospective comparative study.

Authors:  Masatoshi Hori; Tonsok Kim; Hiromitsu Onishi; Izumi Imaoka; Yuki Kagawa; Takamichi Murakami; Atsushi Nakamoto; Takashi Ueguchi; Mitsuaki Tatsumi; Takayuki Enomoto; Tadashi Kimura; Noriyuki Tomiyama
Journal:  Eur Radiol       Date:  2013-03-19       Impact factor: 5.315

9.  Uterine cervical carcinoma: a comparison of two- and three-dimensional T2-weighted turbo spin-echo MR imaging at 3.0 T for image quality and local-regional staging.

Authors:  Y R Shin; S E Rha; B G Choi; S N Oh; M Y Park; J Y Byun
Journal:  Eur Radiol       Date:  2012-08-07       Impact factor: 5.315

10.  Magnetic resonance imaging of uterine fibroids: a preliminary investigation into the usefulness of 3D-rendered images for surgical planning.

Authors:  Sayed Ahmad Zikri B Sayed Aluwee; Hiroki Kato; Xiangrong Zhou; Takeshi Hara; Hiroshi Fujita; Masayuki Kanematsu; Tatsuro Furui; Ryuichiro Yano; Nao Miyai; Ken-Ichirou Morishige
Journal:  Springerplus       Date:  2015-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.